AstraZeneca plc (AZN) PT Lowered to GBX 4,200

AstraZeneca plc (AZN) PT Lowered to GBX 4,200


The firm presently has a "reduce" rating on the biopharmaceutical company's stock. HSBC Holdings plc's price target would indicate a potential downside of 18.86% from the company's previous close.



from Biotech News